{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:45:52Z","timestamp":1792201552010,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:00:00Z","timestamp":1400544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00280-014-2451-7","type":"journal-article","created":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T12:50:27Z","timestamp":1400503827000},"page":"167-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells"],"prefix":"10.1007","volume":"74","author":[{"given":"Han","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ping","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,20]]},"reference":[{"issue":"2","key":"2451_CR1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.onc.1209019","volume":"25","author":"A Chen","year":"2006","unstructured":"Chen A, Xu J, Johnson AC (2006) Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 25(2):278\u2013287","journal-title":"Oncogene"},{"issue":"3","key":"2451_CR2","first-page":"118","volume":"18","author":"KM Mohandas","year":"1999","unstructured":"Mohandas KM, Desai DC (1999) Epidemiology of digestive tract cancers in India. V. Large and small bowel. Indian J Gastroenterol 18(3):118\u2013121","journal-title":"Indian J Gastroenterol"},{"issue":"6960","key":"2451_CR3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature02009","volume":"425","author":"SP Thayer","year":"2003","unstructured":"Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernandez-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425(6960):851\u2013856","journal-title":"Nature"},{"issue":"2","key":"2451_CR4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/WAD.0b013e318260ab97","volume":"27","author":"G Spalletta","year":"2013","unstructured":"Spalletta G, Cravello L, Piras F, Iorio M, Sancesario G, Marchi A, Caltagirone C, Cacciari C (2013) Rapid-onset apathy may be the only clinical manifestation after dorsal striatum hemorrhagic lesion: a case report. Alzheimer Dis Assoc Disord 27(2):192\u2013194","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"6","key":"2451_CR5","doi-asserted-by":"crossref","first-page":"e37030","DOI":"10.1371\/journal.pone.0037030","volume":"7","author":"H Li","year":"2012","unstructured":"Li H, Qian W, Weng X, Wu Z, Zhuang Q, Feng B, Bian Y (2012) Glucocorticoid receptor and sequential P53 activation by dexamethasone mediates apoptosis and cell cycle arrest of osteoblastic MC3T3-E1 cells. PLoS ONE 7(6):e37030","journal-title":"PLoS ONE"},{"issue":"15","key":"2451_CR6","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1074\/jbc.M010604200","volume":"276","author":"V Petronilli","year":"2001","unstructured":"Petronilli V, Penzo D, Scorrano L, Bernardi P, Di Lisa F (2001) The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J Biol Chem 276(15):12030\u201312034","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"2451_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jns.2010.08.051","volume":"299","author":"Y Dong","year":"2010","unstructured":"Dong Y, Sharma VK, Chan BP, Venketasubramanian N, Teoh HL, Seet RC, Tanicala S, Chan YH, Chen C (2010) The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neurol Sci 299(1\u20132):15\u201318","journal-title":"J Neurol Sci"},{"issue":"17","key":"2451_CR8","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","volume":"362","author":"M Hidalgo","year":"2010","unstructured":"Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362(17):1605\u20131617","journal-title":"N Engl J Med"},{"issue":"1","key":"2451_CR9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1158\/0008-5472.CAN-10-2366","volume":"71","author":"T Martinsson","year":"2011","unstructured":"Martinsson T, Eriksson T, Abrahamsson J, Caren H, Hansson M, Kogner P, Kamaraj S, Schonherr C, Weinmar J, Ruuth K, Palmer RH, Hallberg B (2011) Appearance of the novel activating F1174S ALK mutation in neuroblastoma correlates with aggressive tumor progression and unresponsiveness to therapy. Cancer Res 71(1):98\u2013105","journal-title":"Cancer Res"},{"issue":"7215","key":"2451_CR10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nature07399","volume":"455","author":"Y Chen","year":"2008","unstructured":"Chen Y, Takita J, Choi YL, Kato M, Ohira M, Sanada M, Wang L, Soda M, Kikuchi A, Igarashi T, Nakagawara A, Hayashi Y, Mano H, Ogawa S (2008) Oncogenic mutations of ALK kinase in neuroblastoma. Nature 455(7215):971\u2013974","journal-title":"Nature"},{"issue":"3","key":"2451_CR11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","volume":"3","author":"GM Brodeur","year":"2003","unstructured":"Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3(3):203\u2013216","journal-title":"Nat Rev Cancer"},{"issue":"6049","key":"2451_CR12","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.333.6049.1569","volume":"333","author":"J Couzin-Frankel","year":"2011","unstructured":"Couzin-Frankel J (2011) Personalized medicine. Pushing the envelope in neuroblastoma therapy. Science 333(6049):1569\u20131571","journal-title":"Science"},{"issue":"7215","key":"2451_CR13","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nature07261","volume":"455","author":"YP Mosse","year":"2008","unstructured":"Mosse YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, Laquaglia MJ, Sennett R, Lynch JE, Perri P, Laureys G, Speleman F, Kim C, Hou C, Hakonarson H, Torkamani A, Schork NJ, Brodeur GM, Tonini GP, Rappaport E, Devoto M, Maris JM (2008) Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455(7215):930\u2013935","journal-title":"Nature"},{"issue":"1\u20132","key":"2451_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0304-3835(03)00079-X","volume":"197","author":"RA Ross","year":"2003","unstructured":"Ross RA, Biedler JL, Spengler BA (2003) A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors. Cancer Lett 197(1\u20132):35\u201339","journal-title":"Cancer Lett"},{"issue":"3","key":"2451_CR15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0962-8924(03)00002-3","volume":"13","author":"H Gu","year":"2003","unstructured":"Gu H, Neel BG (2003) The \u201cGab\u201d in signal transduction. Trends Cell Biol 13(3):122\u2013130","journal-title":"Trends Cell Biol"},{"issue":"15","key":"2451_CR16","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1158\/1078-0432.CCR-05-0081","volume":"11","author":"H Mackay","year":"2005","unstructured":"Mackay H, Hedley D, Major P, Townsley C, Mackenzie M, Vincent M, Degendorfer P, Tsao MS, Nicklee T, Birle D, Wright J, Siu L, Moore M, Oza A (2005) A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer. Clin Cancer Res 11(15):5526\u20135533","journal-title":"Clin Cancer Res"},{"issue":"23","key":"2451_CR17","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H Hurwitz","year":"2004","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350(23):2335\u20132342","journal-title":"N Engl J Med"},{"issue":"9","key":"2451_CR18","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1158\/0008-5472.CAN-07-6109","volume":"68","author":"S Uddin","year":"2008","unstructured":"Uddin S, Ahmed M, Bavi P, El-Sayed R, Al-Sanea N, AbdulJabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Hussain AR, Al-Kuraya KS (2008) Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer. Cancer Res 68(9):3379\u20133388","journal-title":"Cancer Res"},{"issue":"3","key":"2451_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/156800911794519752","volume":"11","author":"D Chen","year":"2011","unstructured":"Chen D, Frezza M, Schmitt S, Kanwar J, Dou QP (2011) Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives. Curr Cancer Drug Targets 11(3):239\u2013253","journal-title":"Curr Cancer Drug Targets"},{"issue":"16","key":"2451_CR20","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1158\/1078-0432.CCR-09-2882","volume":"16","author":"JJ Wright","year":"2010","unstructured":"Wright JJ (2010) Combination therapy of bortezomib with novel targeted agents: an emerging treatment strategy. Clin Cancer Res 16(16):4094\u20134104","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2451_CR21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2239","volume":"8","author":"MC Maiuri","year":"2007","unstructured":"Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8(9):741\u2013752","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"Suppl 2","key":"2451_CR22","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/sj.cdd.4401751","volume":"12","author":"P Codogno","year":"2005","unstructured":"Codogno P, Meijer AJ (2005) Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 12(Suppl 2):1509\u20131518","journal-title":"Cell Death Differ"},{"issue":"5497","key":"2451_CR23","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","volume":"290","author":"DJ Klionsky","year":"2000","unstructured":"Klionsky DJ, Emr SD (2000) Autophagy as a regulated pathway of cellular degradation. Science 290(5497):1717\u20131721","journal-title":"Science"},{"issue":"10","key":"2451_CR24","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1172\/JCI26390","volume":"115","author":"B Levine","year":"2005","unstructured":"Levine B, Yuan J (2005) Autophagy in cell death: an innocent convict? J Clin Invest 115(10):2679\u20132688","journal-title":"J Clin Invest"},{"issue":"9","key":"2451_CR25","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","volume":"13","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova MM, Shaw RJ (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13(9):1016\u20131023","journal-title":"Nat Cell Biol"},{"issue":"10","key":"2451_CR26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nrm2249","volume":"8","author":"DG Hardie","year":"2007","unstructured":"Hardie DG (2007) AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8(10):774\u2013785","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2451_CR27","doi-asserted-by":"crossref","unstructured":"Zheng QY, Jin FS, Yao C, Zhang T, Zhang GH, Ai X (2012) Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells. Biochem Biophys Res Commun","DOI":"10.1016\/j.bbrc.2012.02.093"},{"issue":"12","key":"2451_CR28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/CS20110625","volume":"122","author":"S Wang","year":"2012","unstructured":"Wang S, Song P, Zou MH (2012) AMP-activated protein kinase, stress responses and cardiovascular diseases. Clin Sci (Lond) 122(12):555\u2013573","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"2451_CR29","doi-asserted-by":"crossref","first-page":"e47049","DOI":"10.1371\/journal.pone.0047049","volume":"7","author":"YQ Liu","year":"2012","unstructured":"Liu YQ, Cheng X, Guo LX, Mao C, Chen YJ, Liu HX, Xiao QC, Jiang S, Yao ZJ, Zhou GB (2012) Identification of an annonaceous acetogenin mimetic, AA005, as an AMPK activator and autophagy inducer in colon cancer cells. PLoS ONE 7(10):e47049","journal-title":"PLoS ONE"},{"issue":"7400","key":"2451_CR30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature11066","volume":"485","author":"SM Jeon","year":"2012","unstructured":"Jeon SM, Chandel NS, Hay N (2012) AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485(7400):661\u2013665","journal-title":"Nature"},{"issue":"2","key":"2451_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan KL (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13(2):132\u2013141","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2451_CR32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-2443.2003.00615.x","volume":"8","author":"N Kimura","year":"2003","unstructured":"Kimura N, Tokunaga C, Dalal S, Richardson C, Yoshino K, Hara K, Kemp BE, Witters LA, Mimura O, Yonezawa K (2003) A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 8(1):65\u201379","journal-title":"Genes Cells"},{"issue":"2","key":"2451_CR33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tips.2004.12.011","volume":"26","author":"Z Luo","year":"2005","unstructured":"Luo Z, Saha AK, Xiang X, Ruderman NB (2005) AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 26(2):69\u201376","journal-title":"Trends Pharmacol Sci"},{"issue":"6016","key":"2451_CR34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"DF Egan","year":"2011","unstructured":"Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, Asara JM, Fitzpatrick J, Dillin A, Viollet B, Kundu M, Hansen M, Shaw RJ (2011) Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331(6016):456\u2013461","journal-title":"Science"},{"issue":"3","key":"2451_CR35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cellsig.2013.11.032","volume":"26","author":"M Krausova","year":"2014","unstructured":"Krausova M, Korinek V (2014) Wnt signaling in adult intestinal stem cells and cancer. Cell Signal 26(3):570\u2013579","journal-title":"Cell Signal"},{"issue":"18","key":"2451_CR36","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1101\/gad.1015202","volume":"16","author":"DW Chan","year":"2002","unstructured":"Chan DW, Chen BP, Prithivirajsingh S, Kurimasa A, Story MD, Qin J, Chen DJ (2002) Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev 16(18):2333\u20132338","journal-title":"Genes Dev"},{"issue":"1\u20132","key":"2451_CR37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11010-013-1746-z","volume":"383","author":"R Lin","year":"2013","unstructured":"Lin R, Wang S, Zhao RC (2013) Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model. Mol Cell Biochem 383(1\u20132):13\u201320","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"2451_CR38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ceb.2013.01.004","volume":"25","author":"JD Holland","year":"2013","unstructured":"Holland JD, Klaus A, Garratt AN, Birchmeier W (2013) Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol 25(2):254\u2013264","journal-title":"Curr Opin Cell Biol"},{"issue":"6762","key":"2451_CR39","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/45257","volume":"402","author":"XH Liang","year":"1999","unstructured":"Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402(6762):672\u2013676","journal-title":"Nature"},{"issue":"8","key":"2451_CR40","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/cdd.2008.51","volume":"15","author":"F Scarlatti","year":"2008","unstructured":"Scarlatti F, Maffei R, Beau I, Codogno P, Ghidoni R (2008) Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ 15(8):1318\u20131329","journal-title":"Cell Death Differ"},{"key":"2451_CR41","doi-asserted-by":"crossref","unstructured":"Koyama-Nasu R, Haruta R, Nasu-Nishimura Y, Taniue K, Katou Y, Shirahige K, Todo T, Ino Y, Mukasa A, Saito N, Matsui M, Takahashi R, Hoshino-Okubo A, Sugano H, Manabe E, Funato K, Akiyama T (2013) The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells. Oncogene","DOI":"10.1038\/onc.2013.168"},{"issue":"1","key":"2451_CR42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.canlet.2011.09.020","volume":"314","author":"C Li","year":"2012","unstructured":"Li C, Johnson DE (2012) Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation. Cancer Lett 314(1):102\u2013107","journal-title":"Cancer Lett"},{"issue":"9","key":"2451_CR43","doi-asserted-by":"crossref","first-page":"e75965","DOI":"10.1371\/journal.pone.0075965","volume":"8","author":"M Granato","year":"2013","unstructured":"Granato M, Santarelli R, Lotti LV, Di Renzo L, Gonnella R, Garufi A, Trivedi P, Frati L, D\u2019Orazi G, Faggioni A, Cirone M (2013) JNK and macroautophagy activation by bortezomib has a pro-survival effect in primary effusion lymphoma cells. PLoS ONE 8(9):e75965","journal-title":"PLoS ONE"},{"issue":"7","key":"2451_CR44","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/carcin\/bgr031","volume":"32","author":"MT Rosenfeldt","year":"2011","unstructured":"Rosenfeldt MT, Ryan KM (2011) The multiple roles of autophagy in cancer. Carcinogenesis 32(7):955\u2013963","journal-title":"Carcinogenesis"},{"issue":"16","key":"2451_CR45","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1038\/sj.onc.1207521","volume":"23","author":"D Gozuacik","year":"2004","unstructured":"Gozuacik D, Kimchi A (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23(16):2891\u20132906","journal-title":"Oncogene"},{"issue":"20","key":"2451_CR46","doi-asserted-by":"crossref","first-page":"16772","DOI":"10.1074\/jbc.M010660200","volume":"276","author":"GE Stoica","year":"2001","unstructured":"Stoica GE, Kuo A, Aigner A, Sunitha I, Souttou B, Malerczyk C, Caughey DJ, Wen D, Karavanov A, Riegel AT, Wellstein A (2001) Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin. J Biol Chem 276(20):16772\u201316779","journal-title":"J Biol Chem"},{"issue":"7215","key":"2451_CR47","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature07397","volume":"455","author":"RE George","year":"2008","unstructured":"George RE, Sanda T, Hanna M, Frohling S, Luther W 2nd, Zhang J, Ahn Y, Zhou W, London WB, McGrady P, Xue L, Zozulya S, Gregor VE, Webb TR, Gray NS, Gilliland DG, Diller L, Greulich H, Morris SW, Meyerson M, Look AT (2008) Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature 455(7215):975\u2013978","journal-title":"Nature"},{"issue":"3","key":"2451_CR48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1568009033481976","volume":"3","author":"A Yart","year":"2003","unstructured":"Yart A, Mayeux P, Raynal P (2003) Gab1, SHP-2 and other novel regulators of Ras: targets for anticancer drug discovery? Curr Cancer Drug Targets 3(3):177\u2013192","journal-title":"Curr Cancer Drug Targets"},{"issue":"23","key":"2451_CR49","doi-asserted-by":"crossref","first-page":"16895","DOI":"10.1074\/jbc.M112.434217","volume":"288","author":"YX Fan","year":"2013","unstructured":"Fan YX, Wong L, Marino MP, Ou W, Shen Y, Wu WJ, Wong KK, Reiser J, Johnson GR (2013) Acquired substrate preference for GAB1 protein bestows transforming activity to ERBB2 kinase lung cancer mutants. J Biol Chem 288(23):16895\u201316904","journal-title":"J Biol Chem"},{"issue":"7215","key":"2451_CR50","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature07398","volume":"455","author":"I Janoueix-Lerosey","year":"2008","unstructured":"Janoueix-Lerosey I, Lequin D, Brugieres L, Ribeiro A, de Pontual L, Combaret V, Raynal V, Puisieux A, Schleiermacher G, Pierron G, Valteau-Couanet D, Frebourg T, Michon J, Lyonnet S, Amiel J, Delattre O (2008) Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 455(7215):967\u2013970","journal-title":"Nature"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2451-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-014-2451-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2451-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T15:53:43Z","timestamp":1565452423000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-014-2451-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,20]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["2451"],"URL":"https:\/\/doi.org\/10.1007\/s00280-014-2451-7","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,20]]}}}